Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors
Clinical trial NCT06094426 · TERMINATED
Trial details
- NCT number
- NCT06094426
- Sponsor
- Grit Biotechnology
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-26
- Primary completion
- 2025-12-30
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.